Multiple executives at Tempus AI Inc. executed significant share sales totaling $20.3 million between Feb. 4-7, according to ...

Chief Operating Officer Ryan Fukushima recently sold a significant portion of his holdings in the company, according to a ...

In a regulatory filing, Tempus AI (TEM) disclosed that COO Ryan Fukushima sold 20,000 shares of the company’s stock. The ...

A very well-timed investment into a medical AI company has more than doubled Pelosi's investment in just three weeks.

Up about 12%, Tempus AI (NASDAQ:TEM) has been explosive. Helping, its volume just spiked to 18.6 million shares, as compared ...

Tempus AI has delivered an 82% YTD return, outperforming the broader market and AI-themed stocks amidst market volatility.

Let's explore the Tempus AI stock price and whether it is a good company to buy and hold despite its overvaluation.

Tempus AI's innovative products are transforming the healthcare industry, with a focus on oncology and large market ...

Looking at options history for Tempus AI TEM we detected 21 trades. If we consider the specifics of each trade, it is ...

Tempus Wealth Planning LLC raised its stake in shares of Alphabet Inc. (NASDAQ:GOOG – Free Report) by 1.7% during the fourth ...

TD Cowen analyst Dan Brennan reinstated coverage of Tempus AI (TEM) with a Buy rating and price target of $74, up from $58, following the ...